Nikita Polyakov

Mr. Nikita Polyakov

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AKAlexey Kostarnoy
Alexey Kostarnoy
PGPetya G. Gancheva
Petya G. Gancheva
BLBernd Lepenies
Bernd Lepenies
Amir I. TukhvatulinAmir I. Tukhvatulin
Amir I. Tukhvatulin
ADAlina S. Dzharullaeva
Alina S. Dzharullaeva
AGAlexander L. Gintsburg
Alexander L. Gintsburg
Significance: Post-traumatic sterile inflammation is the first necessary step of wound healing. In addition, sterile inflammation underlies the pathogenesis of a multitude of common diseases, such as allergies and autoimmune diseases. The molecular mechanisms underlying sterile inflammation are still not fully understood. Here, we show that the receptor Mincle (Clec4e), the expression of which is highly induced in the skin in response to damage, recognizes cholesterol sulfate, a molecule that is abundant in the epidermal layer of the skin, subsequently inducing a pro-inflammatory response. We also identify a role for Mincle as a driving component in the pathogenesis of allergic skin inflammation. The results demonstrate a previously unconsidered important role of Mincle in mediating sterile inflammation.

24 October 2003 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
SBStanislav G Batrakov
Stanislav G Batrakov
TRTatiana A Rodionova
Tatiana A Rodionova
SEStanislav E Esipov
Stanislav E Esipov
NPNikita Polyakov
Nikita Polyakov
VSVladimir I Sheichenko
Vladimir I Sheichenko
YNYury Nikolaev
Yury Nikolaev

16 May 2019 in Molecules
Verified
Journal Article
Open access
PDF file
AGAlexander Grishin
Alexander Grishin
NLNatalia V. Lavrova
Natalia V. Lavrova
ALAlexander M. Lyashchuk
Alexander M. Lyashchuk
NSNatalia Strukova
Natalia Strukova
MGMaria S. Generalova
Maria S. Generalova
VLVladimir G. Lunin
Vladimir G. Lunin
The increasing prevalence of antibiotic-resistant strains of pathogenic bacteria is a major healthcare problem. Antibacterial lysins are enzymes that cleave the peptidoglycan of the bacterial cell wall. These proteins hold potential as a supplement or an alternative to traditional antibiotics since they are active against antibiotic resistant strains. However, antibacterial lysins are rapidly eliminated from the systemic circulation, which limits their application. Dimerization of an anti-pneumococcal lysin Cpl-1 has been demonstrated to decrease the clearance rate of this protein in mice. In the present work, we constructed a dimer of an anti-staphylococcal lysin lysostaphin by fusing it with an anti-parallel α-helical dimerization domain. Lysostaphin dimer had a more favorable pharmacokinetic profile with increased terminal half-life and area under the curve (AUC) values compared to monomeric lysostaphin. However, the staphylolytic activity of dimerized lysostaphin was decreased. This decrease in activity was likely caused by the dimerization; since the catalytic efficacy of lysostaphin dimer towards pentaglycine peptide was unaltered. Our results demonstrate that, although dimerization is indeed beneficial for the pharmacokinetics of antibacterial lysins, this approach might not be suitable for all lysins, as it can negatively affect the lysin activity.

9 August 2019 in Molecules
Verified
Journal Article
Open access
PDF file
AGAlexander Grishin
Alexander Grishin
NSNikita V. Shestak
Nikita V. Shestak
NLNatalia V. Lavrova
Natalia V. Lavrova
ALAlexander M. Lyashchuk
Alexander M. Lyashchuk
LPLiubov I. Popova
Liubov I. Popova
VLVladimir G. Lunin
Vladimir G. Lunin
Antibacterial lysins are promising proteins that are active against both antibiotic-susceptible and antibiotic-resistant bacterial strains. However, a major limitation of antibacterial lysins is their fast elimination from systemic circulation. PEGylation increases the plasma half-life of lysins but renders them inactive. Here we report the construction of a fusion protein of lysostaphin, a potent anti-staphylococcal lysin, and an albumin-binding domain from streptococcal protein G. The resulting fusion protein was less active than the parent enzyme lysostaphin, but it still retained significant antibacterial activity even when bound to serum albumin. The terminal half-life of the fusion protein in rats was five-fold greater than that of lysostaphin (7.4 vs. 1.5 h), and the area under the curve increased more than 115 times. Most importantly, this increase in systemic circulation time compensated for the decrease in activity. The plasma from rats that received an injection of the fusion protein retained bactericidal activity for up to 7 h, while plasma from rats that received plain lysostaphin lacked any detectable activity after 4 h. To the best of our knowledge, this is the first report of an antibacterial lysin with both improved pharmacokinetic parameters and prolonged bactericidal activity in the systemic circulation.

1 October 2010 in Inorganic Materials: Applied Research
Verified
Journal Article
Closed access
PDF file
SBSergey Aleksandrovich Bedin
Sergey Aleksandrovich Bedin
ORO. G. Rybalko
O. G. Rybalko
NPNikita Polyakov
Nikita Polyakov
DZD. L. Zagorskii
D. L. Zagorskii
ARA. V. Razumovskaya
A. V. Razumovskaya
VOVladimir A. Oleinikov
Vladimir A. Oleinikov
Cylindrical and conical micro- and nanowires were fabricated by matrix (template) synthesis in pores of track membranes. A technique for filling matrix pores with metal (copper, nickel, and silver)...

14 March 2018 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
ADAlina S. Dzharullaeva
Alina S. Dzharullaeva
Amir I. TukhvatulinAmir I. Tukhvatulin
Amir I. Tukhvatulin
AEAlina S. Erokhova
Alina S. Erokhova
BABandelyuk Alina
Bandelyuk Alina
NPNikita Polyakov
Nikita Polyakov
AGAlexander L. Gintsburg
Alexander L. Gintsburg
Induction of a robust and long-lived mucosal immune response during vaccination is critical to achieve protection against numerous pathogens. However, traditional injected vaccines are generally poor inducers of mucosal immunity. One of the effective strategies to improve vaccine efficacy is incorporation of adjuvant molecules that enhance and polarize adaptive immune reactions. Effects of Syk-coupled lectin receptor agonists as adjuvants to induce mucosal immune reactions during parenteral immunization are not fully studied. We now report that the agonists trehalose-6,6-dibehenate (TDB), curdlan, and furfurman, which stimulate Dectin-1, Dectin-2, and Mincle, respectively, activate transcription factors (NF-κB, NFAT, and AP-1) to various extents in murine RAW 264.7 macrophages, even though similar pathways are activated. The agonists also elicit differential expression of maturation markers in bone marrow-derived dendritic cells, as well as differential cytokine secretion from these cells and from splenic mononuclear cells. In vivo assays also show that agonists of Dectin-1 and Dectin-2, but not Mincle, induce heavy IgA secretion in intestinal mucosa even when delivered parenterally. Strikingly, this effect appears to be formulation-independent. Collectively, the data suggest that adjuvants based on Dectin-1 and Dectin-2 agonists may significantly improve the efficacy of parenteral vaccines by inducing robust local immune reactions in intestinal mucosa.